San Francisco Sentry Investment Group’s Schwab Fundamental US Large Company Index ETF FNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$190K Hold
10,395
0.1% 209
2021
Q1
$179K Hold
10,395
0.08% 236
2020
Q4
$157K Hold
10,395
0.07% 232
2020
Q3
$134K Hold
10,395
0.07% 232
2020
Q2
$128K Sell
10,395
-150
-1% -$1.77K 0.07% 227
2020
Q1
$110K Buy
10,545
+5,412
+105% +$70.5K 0.07% 205
2019
Q4
$73K Hold
5,133
0.03% 332
2019
Q3
$68K Hold
5,133
0.03% 334
2019
Q2
$67K Hold
5,133
0.03% 339
2019
Q1
$65K Hold
5,133
0.03% 369
2018
Q4
$58K Hold
5,133
0.03% 355
2018
Q3
$68K Hold
5,133
0.03% 365
2018
Q2
$64K Buy
5,133
+390
+8% +$4.85K 0.03% 364
2018
Q1
$57K Hold
4,743
0.02% 437
2017
Q4
$59K Buy
+4,743
New +$57.3K 0.02% 422

Other funds holding FNDX

San Francisco Sentry Investment Group's FNDX Position: Q2 2021 in Review

San Francisco Sentry Investment Group held its Schwab Fundamental US Large Company Index ETF (FNDX) position steady in Q2 2021 at 10,395 shares worth $190K. The position accounts for 0.1% of the portfolio, ranked #209.

San Francisco Sentry Investment Group first reported a position in FNDX in Q4 2017 and has held it in 15 quarters since. 280 funds tracked by Wall St. Rank hold FNDX as of Q2 2021.

  • San Francisco Sentry Investment Group held 10,395 shares of Schwab Fundamental US Large Company Index ETF worth $190K as of Q2 2021.
  • San Francisco Sentry Investment Group left its Schwab Fundamental US Large Company Index ETF share count unchanged in Q2 2021.
  • Schwab Fundamental US Large Company Index ETF made up 0.1% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #209 holding.
  • San Francisco Sentry Investment Group first reported a position in Schwab Fundamental US Large Company Index ETF in Q4 2017 and has held it in 15 quarters since.
  • 280 funds tracked by Wall St. Rank held Schwab Fundamental US Large Company Index ETF as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.